What oral iron formulation provides the best tolerability for a child younger than 12 years?

Best Oral Iron for Children Under 12: Tolerability

For children under 12 requiring oral iron supplementation, iron-fortified infant formula or iron drops (ferrous sulfate) at 1-2 mg/kg/day should be the first-line choice for infants, while low-dose ferrous sulfate (3 mg/kg/day once daily) is recommended for children aged 9 months to 12 years, despite newer formulations claiming better tolerability.

Evidence-Based Reasoning

The CDC guidelines 1 provide the foundational framework: enteral iron supplementation should be preferentially given over parenteral routes when tolerated 2. This establishes oral iron as the standard approach for children.

Age-Specific Recommendations

For Infants (0-12 months):

• Breast-fed infants: 1 mg/kg/day of iron drops starting at 6 months if supplementary foods provide insufficient iron 1
• Preterm/low birthweight infants: 2-4 mg/kg/day (maximum 15 mg/day) starting at 1 month 1
• Formula-fed infants: Use only iron-fortified formula 1
• Iron-fortified infant cereal at 4-6 months provides adequate iron with two or more servings daily 1

For Children 9 months to 12 years:

• Treatment dose: 3 mg/kg/day of ferrous sulfate 1
• This lower once-daily dosing has proven efficacy while minimizing gastrointestinal side effects

Formulation Comparison: What the Evidence Actually Shows

Ferrous Sulfate (Standard of Care)

The highest quality recent evidence 3 demonstrates that low-dose ferrous sulfate (3 mg/kg once daily) significantly outperforms iron polysaccharide complex in children aged 9-48 months with iron deficiency anemia. Hemoglobin increased by 4.0 g/dL with ferrous sulfate versus 3.4 g/dL with iron polysaccharide complex (difference of 1.0 g/dL, 95% CI 0.4-1.6, P<0.001). Complete resolution of anemia occurred in 29% versus only 6% (P=0.04). Notably, diarrhea was actually MORE common with iron polysaccharide complex (58%) than ferrous sulfate (35%, P=0.04), contradicting the assumption that newer formulations are better tolerated.

Ferric Maltol (Newer Option)

Recent 2026 data 4 shows ferric maltol increased hemoglobin by 1.25 g/dL in children aged 2-17 years, with better palatability ratings (79.3% rated OK/Good/Very Good versus 50% for ferrous sulfate, P=0.027). However, this study was stopped early at interim analysis and lacks the statistical power of longer-term comparisons. Ferric maltol is only FDA-approved for children ≥10 years 5.

Iron Polymaltose Complex

A 2011 study 6 showed comparable efficacy between iron polymaltose complex and ferrous sulfate (hemoglobin increases of 2.3 vs 3.0 g/dL at 4 months), with fewer gastrointestinal adverse events (26.9% vs 50.9%, P=0.012). However, this older study used twice-daily ferrous sulfate dosing, which is known to cause more side effects than once-daily dosing.

Liposomal Iron

The most recent 2025 data 7 actually shows liposomal iron was INFERIOR to ferrous ascorbate for increasing hemoglobin (rise of 0.1 g/dL vs 1.0 g/dL, P=0.0018), despite better tolerability. This contradicts marketing claims about liposomal formulations.

Clinical Algorithm

Step 1: Determine age and iron needs

• Infants <6 months: Breast milk or iron-fortified formula only
• Infants 6-12 months: Iron-fortified cereal + iron drops if needed (1 mg/kg/day)
• Children >9 months with confirmed IDA: Ferrous sulfate 3 mg/kg/day once daily

Step 2: Optimize absorption and minimize side effects

• Administer between meals when possible
• Pair with vitamin C-rich foods/juice 1
• Consider alternate-day dosing if daily dosing causes intolerable side effects 8 - recent evidence suggests similar efficacy with fewer adverse effects

Step 3: If ferrous sulfate not tolerated

• Try alternate-day ferrous sulfate first (once or twice weekly) 9
• Consider iron polymaltose complex (once daily dosing) 6
• Ferric maltol for children ≥10 years if other options fail 4, 5

Step 4: Monitor response

• Recheck hemoglobin at 4 weeks - expect ≥1 g/dL increase 1
• Continue treatment for 2-3 months after normalization to replenish stores 1
• Repeat hemoglobin/hematocrit 6 months after successful treatment 1

Critical Pitfalls to Avoid

1. Don't assume newer = better tolerated: The 2017 JAMA trial 3 definitively shows low-dose ferrous sulfate has comparable or better tolerability than "better tolerated" alternatives, while being significantly more effective.

2. Avoid excessive dosing: Traditional twice-daily dosing (6 mg/kg/day total) causes more side effects without additional benefit. Once-daily 3 mg/kg dosing is the evidence-based standard 3.

3. Don't use cow's milk before 12 months: This impairs iron absorption and can cause occult GI bleeding 1. Limit to ≤24 oz/day in children 1-5 years 1.

4. Don't continue ineffective therapy: If hemoglobin doesn't increase ≥1 g/dL after 4 weeks despite compliance, investigate other causes of anemia 1.

5. Beware of iron overdose risk: Ferrous sulfate has lower safety margin than carbonyl iron in accidental overdose 9. Store safely away from children.

Bottom Line

Despite marketing claims about superior tolerability of newer iron formulations, the strongest recent evidence supports low-dose ferrous sulfate (3 mg/kg once daily) as the optimal first-line oral iron for children under 12. It provides superior efficacy, comparable or better tolerability when dosed appropriately, and is the most cost-effective option. Reserve alternative formulations for the minority of patients who genuinely cannot tolerate ferrous sulfate despite proper dosing strategies.